Pregled bibliografske jedinice broj: 1030893
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study // Rheumatology, 1 (2019), 31680161, 11 doi:10.1093/rheumatology/kez486 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1030893 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study
Autori
Jaeger, VK ; Tikly, M ; Xu, D ; Siegert, E ; Hachulla, E ; Airò, P ; Valentini, G ; Matucci Cerinic, M ; Distler, O ; Cozzi, F ; Carreira, P ; Allanore, Y ; Müller-Ladne, r U ; Ananieva, LP ; Balbir-Gurman, A ; Distler, JHW ; Czirják, L ; Li, M ; Henes, J ; Jimenez, SA ; Smith, V ; Damjanov, N ; Denton, CP ; DelGaldo, F ; Saketkoo, LA ; Walker, UA ; EUSTAR, co-authors
Izvornik
Rheumatology (1462-0324) 1
(2019);
31680161, 11
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
organ manifestations ; races ; systemic sclerosis
Sažetak
OBJECTIVES: Racial factors play a significant role in SSc. We evaluated differences in SSc presentations between white patients (WP), Asian patients (AP) and black patients (BP) and analysed the effects of geographical locations. METHODS: SSc characteristics of patients from the EUSTAR cohort were cross-sectionally compared across racial groups using survival and multiple logistic regression analyses. RESULTS: The study included 9162 WP, 341 AP and 181 BP. AP developed the first non-RP feature faster than WP but slower than BP. AP were less frequently anti-centromere (ACA ; odds ratio (OR) = 0.4, P < 0.001) and more frequently anti-topoisomerase-I autoantibodies (ATA) positive (OR = 1.2, P = 0.068), while BP were less likely to be ACA and ATA positive than were WP [OR(ACA) = 0.3, P < 0.001 ; OR(ATA) = 0.5, P = 0.020]. AP had less often (OR = 0.7, P = 0.06) and BP more often (OR = 2.7, P < 0.001) diffuse skin involvement than had WP. AP and BP were more likely to have pulmonary hypertension [OR(AP) = 2.6, P < 0.001 ; OR(BP) = 2.7, P = 0.03 vs WP] and a reduced forced vital capacity [OR(AP) = 2.5, P < 0.001 ; OR(BP) = 2.4, P < 0.004] than were WP. AP more often had an impaired diffusing capacity of the lung than had BP and WP [OR(AP vs BP) = 1.9, P = 0.038 ; OR(AP vs WP) = 2.4, P < 0.001]. After RP onset, AP and BP had a higher hazard to die than had WP [hazard ratio (HR) (AP) = 1.6, P = 0.011 ; HR(BP) = 2.1, P < 0.001]. CONCLUSION: Compared with WP, and mostly independent of geographical location, AP have a faster and earlier disease onset with high prevalences of ATA, pulmonary hypertension and forced vital capacity impairment and higher mortality. BP had the fastest disease onset, a high prevalence of diffuse skin involvement and nominally the highest mortality.
Izvorni jezik
Engleski
POVEZANOST RADA
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE